Upstream transcription factor 1 suppresses laryngeal squamous cell carcinoma progression through transcriptional activation of junctional adhesion molecule 3
IUBMB Life · 2025
DOI: 10.1002/iub.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, 2025. Verfasst von Yue Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of First Clinical Medicine, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Laryngeal Neoplasms, Gene Expression Regulation, Neoplastic, Transcriptional Activation. Die Arbeit nennt 42 Literaturangaben. Gefördert von: The Research Project of the First Hospital of Shanxi Medical University (136 Special Projects).
Abstract (Originalsprache)
Laryngeal squamous cell carcinoma (LSCC) exhibits aggressive growth, frequent recurrence, and a notable resistance to existing treatments. Building upon prior discoveries that identified junctional adhesion molecule 3 (JAM3) as a critical tumor suppressor in LSCC, this study delves into the transcriptional regulation by upstream stimulatory factor 1 (USF1) and its implications for LSCC pathogenesis. Employing dual‐luciferase assays and chromatin immunoprecipitation–quantitative polymerase chain reaction (ChIP‐qPCR), we confirmed USF1's direct binding to the E‐box within the JAM3 promoter, thereby enhancing JAM3 expression in AMC‐HN‐8 and FD‐LSC‐1 cells. Complementary in vitro assays and in vivo experiments corroborated that USF1 overexpression markedly reduces tumor aggressiveness, linked to heightened JAM3 activity. Further analysis, including Western blot and immunohistochemistry of xenograft tumor tissues, revealed that increased JAM3, stimulated by USF1, activates the Hippo signaling pathway, underscoring its role in tumor suppression. These findings position USF1 and JAM3 as pivotal elements in the molecular framework of LSCC, suggesting their potential as targets for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of First Clinical Medicine, Shanxi Medical University, Taiyuan, China.
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, Taiyuan, China.
- Department of Otolaryngology Head & Neck Surgery, The First Hospital, Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Hui Huangfu
Förderung
- The Research Project of the First Hospital of Shanxi Medical University (136 Special Projects)
Zitieren
APA
Jia, Y., Liu, J., Lou, Y., Wang, X., Zhang, C., Guo, Y., & Huangfu, H. (2025). Upstream transcription factor 1 suppresses laryngeal squamous cell carcinoma progression through transcriptional activation of junctional adhesion molecule 3. IUBMB Life. https://doi.org/10.1002/iub.70013
Vancouver
Jia Y, Liu J, Lou Y, Wang X, Zhang C, Guo Y, et al. Upstream transcription factor 1 suppresses laryngeal squamous cell carcinoma progression through transcriptional activation of junctional adhesion molecule 3. IUBMB Life. 2025. doi:10.1002/iub.70013
BibTeX
@article{Jia2025,
author = {Jia, Yue and Liu, Jiaojiao and Lou, Yichen and Wang, Xinfang and Zhang, Chunming and Guo, Yujia and Huangfu, Hui},
title = {Upstream transcription factor 1 suppresses laryngeal squamous cell carcinoma progression through transcriptional activation of junctional adhesion molecule 3},
journal = {IUBMB Life},
year = {2025},
doi = {10.1002/iub.70013}
}
EUVIMED